Abstract:Background: Pathophysiologic changes of posttransplant lung ischemia/reperfusion injury are mediated by redundant cellular and humoral mechanisms. We investigated the protective effect of combined administration of platelet activating factor (PAF) and endothelin (ET) antagonists after prolonged ischemia in a small animal lung transplantation model.Methods: Orthotopic left Lung transplantation was performed after 20 hours cold ischemia in male Fischer (F344) rats weighing 200-250 g. Group I served as control. Ih Group II, donors received 1 mg/kg body weight of the endothelin antagonist TAK-044, and recipients 2 mg/kg. Group III was treated with the PAF antagonist TCV-309 (donor: 50 mu g/kg; recipient: 100 mu g/kg) (Takeda Chemicals Ltd.). Group IV received a combined treatment with both substances at the same dosage. Twenty-four hours after reperfusion, the native contralateral lung was occluded to assess gas exchange of the graft only, and 5 minutes later the thoracic aorta was punctured for arterial blood gas analysis (n = 5). In other animals (n = 5), lung tissue was frozen 24 hours after reperfusion and assessed for myeloperoxidase activity (MPO) and thiobarbituric acid reactive substances.Results: Combined inhibition of PAF and ET-1 at the receptor level resulted in significantly improved graft function as compared to controls (Group I), and to groups treated with either TAK-044 or TCV-309. This was determined by a higher arterial oxygen content (112 +/- 9 mmHg, p = .00061 vs control, 48 +/- 5 mmHg), reduced MPO activity (0.35 +/- 0.02 Delta hOD/mg/min,p = .000002 vs control, 1.1 +/- 0.1 Delta OD/mg/min) and reduced lipid peroxidation (59.5 +/- 2.5 pmol/g, p = .011 vs control, 78.5 +/- 4.1 pmol/g). The improvement of arterial oxygen (Group II 77 +/- 10 mmHg, p = .027 vs control; Group III 84 +/- 8 mmHg, p = .0081 vs control) and reduction of MPO activity (Group II 0.85 +/- 0.061 Delta OD/mg/min,p = .017; Group III 0.92 +/- 0.079 Delta OD/mg/min, p = .058) in groups treated with either a PAF antagonist or an ET antagonist was significantly less than in Group IV.Conclusions: Combined donor and recipient treatment with an ET antagonist and a PAF antagonist results in superior posttransplant graft function 24 hours after reperfusion, suggesting a synergistic role of ET-1 and PAF in the mediation of reperfusion injury in this model. Single treatment with either of the antagonists revealed only a slight improvement compared to untreated controls.

Addition of ATP and MgCl2 to the preservation solution attenuates lung reperfusion injury following cold ischemia

[Protective Effect of Mitochondrial ATP-sensitive Potassium Channel Opener on Rat Heart During Hypothermic Preservation].

The Protective Effect of Diazoxide on Rat Hearts During Hypothermic Preservation

Diazoxide Supplemented Celsior Solution Improves Hypothermic Heart Preservation Effect in Rat Through Activation of Mitochondrial ATP-sensitive Potassium Channel

[The Protective Effect of Diazoxide on Long-Term Heart Preservation].

[Effect of Postconditioning on Rat Hearts Suffered from Long-Term Hypothermic Preservation].

Preconditioning and Postconditioning Reduce Hepatic Ischemia-Reperfusion Injury in Rats

Activation of Mitochondrial Atp-Sensitive Potassium Channel Contributes to Protective Effect in Prolonged Myocardial Preservation

L-Alanyl-L-Glutamine Alleviated Ischemia-Reperfusion Injury and Primary Graft Dysfunction in Rat Lung Transplants

Effects of Adenosine Preconditioning on Myocardium Preservation of Long Term Isolated Rat Heart

Preservation solution Custodiol containing human alpha-1-antitrypsin improves graft recovery after prolonged cold ischemic storage in a rat model of heart transplantation

[Protective Effect of Ischemic Postconditioning on Ischemic Reperfusion Injury of Rat Liver Graft].

Protective effects of 10°C preservation on donor lungs with lipopolysaccharide-induced acute lung injury

Protective effect of exogenous ATP-MgCl2 preconditioning on warm ischemia injury of rat liver graft

Administering a second rinse solution of low-potassium-dextran before reperfusion ameliorates the donor lung

Combined Treatment with Endothelin- and PAF-antagonists Reduces Posttransplant Lung Ischemia/reperfusion Injury.

Protective Effects of Ulinastatin on Ischemia-Reperfusion Iiyury During Rat Non-Heart Beating Donor Lung Transplantation

Trimetazidine protects the energy status after ischemia and reduces reperfusion injury in a rat single lung transplant model

Protective effect of once ischemic pretreatment on recovery of renal function in renal transplantation models of severe ischemical reperfusion injury

High-flow endobronchial cooled humidified air protects non-heart-beating donor rat lungs against warm ischemia

Nitrite Reduces Acute Lung Injury and Improves Survival in a Rat Lung Transplantation Model